Vijaya Diagnostic Centre Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹-10(-1.88%)
Premium (ELP)
Vijaya Diagnostic Centre Limited's successfully transitioned to public market status with its listing on NSE, BSE on Sep 14, 2021. The IPO mobilized 3,56,88,064 Shares in cumulative capital, including TBD for corporate expansion and ₹1895.04 Cr for shareholder liquidity management.
The public offering was conducted within the price parameters of ₹522 to ₹531, with minimum investment lots of 28 shares. subscription activity between Sep 01, 2021 and Sep 03, 2021 demonstrated market reception to the company's valuation and growth narrative.
The allotment process concluded on Sep 08, 2021, finalizing share distribution to successful bidders. The listing represents a transformational event, providing the company with enhanced market visibility, regulatory compliance framework, and access to diversified investor capital.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Established in 1981, Vijaya Diagnostic Centre is a leading diagnostic chain in Southern India, offering comprehensive pathology and radiology services with around 740 routine tests, 870 specialized pathology tests, 220 basic radiology tests, and 320 advanced radiology tests, along with customized health and wellness packages. The company operates 80 diagnostic centers and 11 reference laboratories across 13 cities in Telangana, Andhra Pradesh, the National Capital Region, and Kolkata, with 96.2% of revenue coming from Hyderabad and nearby regions. In the year ended March 31, 2021, Vijaya Diagnostic Centre conducted approximately 6.20 million pathology tests and 0.89 million radiology tests for about 2.63 million customers, and all its laboratories hold NABL accreditation, with three centers also holding NABH accreditation.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Leading Diagnostic Chain: Largest and fastest-growing in Southern India.
- Affordable & Comprehensive Services: One-stop diagnostics with superior quality focus.
- Advanced Technology: Strong technical capabilities with cutting-edge testing and robust IT infrastructure.
- Accredited Laboratories: All labs hold National Accreditation.
- High Brand Recall: Drives strong individual consumer business.
NA
- Dr. S. Surendranath Reddy
Vijaya Diagnostic Centre Limited
Kfin Technologies Limited